BOESS CARSTEN 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
BOESS CARSTEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-22+25,850→ 25,850 totalExercise: $21.56Exp: 2033-06-22→ Common Stock (25,850 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.